AwardedSpainGoods€201,353
Suministro de los principios activos denominados "Faricimab 28,8 MG / 0,24 ML VIAL 0,24 ML Intravitrea" Y "Polatuzumab Vedotina 30MG POLVO PERFUSION".
- Published
- Published 10 March 2025
Overview
The Hospital Universitario de Gran Canaria Doctor Negrín procured the active pharmaceutical ingredients Faricimab 28.8 mg/0.24 ml intravitreal vial and Polatuzumab Vedotina 30 mg infusion powder, classified as miscellaneous medicines. The contract was awarded to Roche Farma, S.A. on 22 January 2025 for a total value of €487,706.10.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €201,353
- Procedure
- Direct
- Published
- 10 March 2025
Various medicinal products
Award outcome
- Awarded value
- €487,706
- Award date
- 22 January 2025
- Roche Farma, S.A.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
10 March 2025
Contracting authority
Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín
Procuring entityLas Palmas de Gran Canaria, Spain
ID_PLATAFORMA: 21050930148853
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.